Lumida
/SANA
⌘K
Sana Biotechnology Inc

Sana Biotechnology Inc

SANA
$3.15USD-0.63%-0.02 today

MARKET CAP

876.6M

P/E (TTM)

FWD P/E

DAY RANGE

$3 – $3

52W RANGE

$3
$7

AI Summary

Stalk
StalkMedium

In a Stage 2 advancing environment, the medium-term bias remains bullish with intact higher highs and higher lows. However, price is currently extended and overbought—trading well above the rising EMAs with RSI and Options Score at stretched levels. Short-term timing is unfavorable for new longs; recommended approach is to stalk pullbacks into the rising EMA support zone (9/21/50) to participate at lower risk.

  • Zacks Rank #2 (Buy) with $8.57 12-month target (~135% upside).
  • 14-month diabetes follow-up data in NEJM boosts clinical credibility.
  • Weak profitability metrics raise questions on operational efficiency.
Full analysis →
Insider Trades12 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Mar 9, 2026SellSANASusan D. Wyrick4,387$3.12$876.6M-51.91%+20.69%$13.7K-1.01%Stalk
Mar 9, 2026SellSANASteve HarrPresident & CEO24,345$3.11$876.6M-51.91%+20.69%$75.8K-0.15%Stalk
Mar 3, 2026SellSANASusan D. Wyrick491$3.91$876.6M-51.91%+20.69%$1.9K-0.26%Stalk
Jan 5, 2026SellSANASusan D. Wyrick2,407$4.27$876.6M-51.91%+20.69%$10.3K-1.28%Stalk
Dec 15, 2025SellSANASusan D. Wyrick873$5.22$876.6M-51.91%+20.69%$4.6K-0.48%Stalk
Jun 4, 2025SellSANASusan D. Wyrick5,132$3.38$876.6M-51.91%+20.69%$17.3K-1.39%Stalk
Mar 10, 2025SellSANASusan D. Wyrick836$2.56$876.6M-51.91%+20.69%$2.1K-0.21%Stalk
Mar 10, 2025SellSANABernard J CassidyEVP & General Counsel2,833$2.56$876.6M-51.91%+20.69%$7.3K-0.64%Stalk
Mar 10, 2025SellSANASteve HarrPresident & CEO12,820$2.56$876.6M-51.91%+20.69%$32.8K-0.14%Stalk
Mar 3, 2025SellSANASusan D. Wyrick490$2.56$876.6M-51.91%+20.69%$1.3K-0.31%Stalk
Jan 2, 2025SellSANASusan D. Wyrick1,566$1.65$876.6M-51.91%+20.69%$2.6K-0.96%Stalk
Dec 15, 2023SellSANAChristian HordoEVP, Chief Business Officer75,000$4.00$876.6M-51.91%+20.69%$300.1K-7.96%10b5-1Stalk